Details
Stereochemistry | EPIMERIC |
Molecular Formula | 2C15H25NO3.C4H6O6 |
Molecular Weight | 684.8146 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@H]([C@@H](O)C(O)=O)C(O)=O.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1.COCCC2=CC=C(OCC(O)CNC(C)C)C=C2
InChI
InChIKey=YGULWPYYGQCFMP-CEAXSRTFSA-N
InChI=1S/2C15H25NO3.C4H6O6/c2*1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3;5-1(3(7)8)2(6)4(9)10/h2*4-7,12,14,16-17H,8-11H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/t;;1-,2-/m..1/s1
Molecular Formula | C15H25NO3 |
Molecular Weight | 267.3639 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | C4H6O6 |
Molecular Weight | 150.0868 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:20:47 UTC 2023
by
admin
on
Fri Dec 15 15:20:47 UTC 2023
|
Record UNII |
W5S57Y3A5L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 331.11
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
||
|
NCI_THESAURUS |
C29576
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
441308
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | |||
|
W5S57Y3A5L
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | |||
|
1441301
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | |||
|
m7498
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB03275MIG
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | |||
|
DBSALT000862
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | |||
|
DTXSID9037248
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | |||
|
56392-17-7
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | |||
|
203191
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | RxNorm | ||
|
W5S57Y3A5L
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | |||
|
CHEMBL13
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | |||
|
260-148-9
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | |||
|
100000090389
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | |||
|
C29255
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY | |||
|
757105
Created by
admin on Fri Dec 15 15:20:47 UTC 2023 , Edited by admin on Fri Dec 15 15:20:47 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
any spot, apart from the principal spot, is not more intense than the spot in the chromatogram obtained with reference solution (a) (0.5 per cent) and at most 1 such spot is more intense than the spot in the chromatogram obtained with reference solution (b) (0.2 per cent)
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
any spot, apart from the principal spot, is not more intense than the spot in the chromatogram obtained with reference solution (a) (0.5 per cent) and at most 1 such spot is more intense than the spot in the chromatogram obtained with reference solution (b) (0.2 per cent)
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
POOR CYP2D6 METABOLIZERS PHARMACOKINETIC PHARMACOKINETIC |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||